A long-term partnership towards a new probiotic certification program based on innovative biotechnology

Lallemand Health Solutions and the Natural Health Product Research Alliance (NHP RA) affiliated with the University of Guelph, both Canadian entities, are…

The first psychobiotic in Brazil

Apsen, located in São Paulo, Brazil, in partnership with Lallemand Health Solutions, are launching in September the first probiotic formulation for the…

Meet ROSELLA: A convenient orally administered probiotic shown to support women’s intimate health

Lallemand Health Solutions will officially launch ROSELLA, its new highly documented licensed strain for Women’s intimate health at Vitafoods Europe Virtual Expo…

Lallemand Health Solutions close a major licensing deal with Proge Farm®

Lallemand Health Solutions and Proge Farm® are proud to announce that they have just closed a major licensing deal for the commercialization…

Lallemand innovative probiotic yeast solutions

As an expert in yeast fermentation and production since 1923, Lallemand presents a wide range of innovative probiotic yeast solutions. Rediscover S.…

Introducing CEREBIOME®: Pioneering psychobiotic. Game-changing science.

Lallemand Health Solutions launches the brand CEREBIOME® (previously known as Probio’Stick®), a new name for an existing formula combining: Lactobacillus helveticus Rosell®-52…

China health authorities’ acknowledge L. helveticus Rosell®-52, B. infantis Rosell®-33 and B. bifidum Rosell®-71 for safe use in infant formula

Lallemand Health Solutions’ three probiotic strains L. helveticus Rosell®-52 (R0052), B. infantis Rosell®-33 (R0033) and B. bifidum Rosell®-71 (R0071), have now completed…

Lallemand group is donating 3,200 personal protective masks

The Lallemand group is donating 3,200 surgical and N95 masks to local health authorities in the Montreal (Canada) and Cantal (France) regions,…

B. LACTIS LAFTI® B94 IS NOW GRAS

One of Lallemand Health Solution’s documented strains, Bifidobacterium lactis Lafti® B94 has recently received a No Questions Letter (NQL) regarding the Generally…